What is Neuralli® MP?

As a provider, you’ve likely worked with probiotics for years – you know they’re live microorganisms that provide health benefits when taken in adequate doses. Traditionally, most research focused on gastrointestinal effects, but in recent years, we’ve begun to understand that certain strains influence systems beyond the gut.

We now recognize that even closely related strains, like those within the species Lactiplantibacillus plantarum, can behave very differently. That’s why today’s research emphasizes strain-level identification: the function of a probiotic depends on its unique characteristics, not just its species.

Neuralli® MP’s active ingredient, L. plantarum PS128™, stands out for the diverse mechanisms through which it acts. Because PS128™ has neurological benefits, it belongs to a specialized class of probiotics called “psychobiotics,” which have been studied for their influence on the gut-brain axis.

So, what makes Neuralli® MP a medical food, not a supplement? It’s a unique category. Medical foods are formulated to be consumed under physician supervision for the specific dietary management of a disease or condition with distinct nutritional needs. Neuralli® MP meets this definition by addressing the unique nutritional requirements associated with autism and Parkinson’s disease.

Mechanistic preclinical research demonstrates the PS128™ strain helps regulate neurotransmitters, modulate immune responses, and beneficially shift gut microbiome metabolism. Together, these mechanisms support its role in managing neurological conditions—and open new possibilities for your patients.